Leap of faith? Buzzy anti-aging biotech Unity pitches an $85M IPO based on mouse data
Can an old mouse that looks and acts youthful and virile inspire investors to back an $85 million IPO?
Unity Biotechnology is about to find …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
